China

Expert Insight

China’s Biotech Boom Demands a New Pharma Strategy

9 September 2026

Podcast

How Cognition Therapeutics Cut Cost of Goods by 85% Through Smarter CMC Strategy

24 August 2026

CDMO News

Aurisco Pharmaceutical Becomes First Generic Oligonucleotide API Manufacturer to Pass USFDA Inspection

13 August 2026

CDMO News

Transcenta to Sell Hangzhou CDMO Assets to WuXi Biologics

10 August 2026

CDMO News

CPC Scientific Completes FDA Pre-License Inspection for Hepcludex® API Manufacturing

6 August 2026

CDMO News

Altruist Biologics Completes First Commercial PPQ Campaign on 20,000L Bioreactors

6 August 2026

CDMO News

Porton Advanced Secures China Drug Manufacturing License for Commercial CGT CDMO Services

6 August 2026

CDMO News

AsymBio Secures 1.2397 Billion(approximately $184 million) Yuan to Expand Biologics CDMO Capacity

5 August 2026

CDMO News

AsymBio Breaks Ground on New Shanghai Biologics R&D Building

28 July 2026

CDMO News

Asymchem’s Carbapenem API Facility Passes First USFDA Pre-Approval Inspection

27 July 2026